Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma
Figure 9. (A–C) ROC analysis of overall survival at 1-, 2- and 3- years for GILncSig, LilncSig, LilncSig and QiulncSig.